424 related articles for article (PubMed ID: 29959132)
1. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
Yegnasubramanian S; De Marzo AM; Nelson WG
Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer epigenetics and its clinical implications.
Yegnasubramanian S
Asian J Androl; 2016; 18(4):549-58. PubMed ID: 27212125
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Modifications and Modulators in Prostate Cancer.
Cimadamore A; Gasparrini S; Scarpelli M; Doria A; Mazzucchelli R; Massari F; Cheng L; Lopez-Beltran A; Montironi R
Crit Rev Oncog; 2017; 22(5-6):439-450. PubMed ID: 29604923
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic targets in the diagnosis and treatment of prostate cancer.
Manoharan M; Ramachandran K; Soloway MS; Singal R
Int Braz J Urol; 2007; 33(1):11-8. PubMed ID: 17335593
[TBL] [Abstract][Full Text] [Related]
5. [Epigenetics of prostate cancer].
Yi XM; Zhou WQ
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):635-41. PubMed ID: 20873600
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics of prostate cancer.
Li LC
Front Biosci; 2007 May; 12():3377-97. PubMed ID: 17485307
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
9. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
10. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modifications in prostate cancer.
Sugiura M; Sato H; Kanesaka M; Imamura Y; Sakamoto S; Ichikawa T; Kaneda A
Int J Urol; 2021 Feb; 28(2):140-149. PubMed ID: 33111429
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer epigenetic biomarkers: next-generation technologies.
Valdés-Mora F; Clark SJ
Oncogene; 2015 Mar; 34(13):1609-18. PubMed ID: 24837368
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Regulation of Chromatin in Prostate Cancer.
Natesan R; Aras S; Effron SS; Asangani IA
Adv Exp Med Biol; 2019; 1210():379-407. PubMed ID: 31900918
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Epigenetic Alterations in Prostate Cancer.
Baumgart SJ; Haendler B
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486411
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
